We thank João Neto and remaining Computational Multi-Omics Lab members at UCIBIO for their helpful comments and suggestions. © 2022. The Author(s).Colorectal cancer (CRC) is a highly diverse disease, where different genomic instability pathways shape genetic clonal diversity and tumor microenvironment. Although intra-tumor heterogeneity has been characterized in primary tumors, its origin and consequences in CRC outcome is not fully understood. Therefore, we assessed intra- and inter-tumor heterogeneity of a prospective cohort of 136 CRC samples. We demonstrate that CRC diversity is forged by asynchronous forms of molecular alterations, where mutational and chromosomal instability collectively boost CRC genetic and microenvironment intra-...
Background: Colorectal cancer is a major global public health problem that has predominantly been co...
Colorectal cancer (CRC) is one of the most common cancers and one of the leading causes of cancer de...
Background & aims: there are few validated biomarkers that can be used to predict outcomes for patie...
© The Author(s) 2022 Open Access This article is licensed under a Creative Commons Attribution 4.0 I...
Genetic heterogeneity between and within tumours is a major factor determining cancer progression an...
Genetic heterogeneity between and within tumours is a major factor determining cancer progression an...
Colorectal cancer harbors tremendous heterogeneity, with temporal and spatial differences in genetic...
The high heterogeneity has become apparent in metastatic colorectal cancer (CRC) and the solitary le...
Colorectal cancer harbors tremendous heterogeneity, with temporal and spatial differences in genetic...
BACKGROUND: Colorectal cancer (CRC) is with approximately 1 million cases the third most common canc...
BACKGROUND: Approximately 4% of colorectal cancer (CRC) patients have at least two simultaneous canc...
The recognition that colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behavio...
Background: Colorectal cancer is a major global public health problem that has predominantly been co...
Background: Colorectal cancer is a major global public health problem that has predominantly been co...
Advanced colorectal cancer harbors extensive intratumor heterogeneity shaped by neutral evolution; h...
Background: Colorectal cancer is a major global public health problem that has predominantly been co...
Colorectal cancer (CRC) is one of the most common cancers and one of the leading causes of cancer de...
Background & aims: there are few validated biomarkers that can be used to predict outcomes for patie...
© The Author(s) 2022 Open Access This article is licensed under a Creative Commons Attribution 4.0 I...
Genetic heterogeneity between and within tumours is a major factor determining cancer progression an...
Genetic heterogeneity between and within tumours is a major factor determining cancer progression an...
Colorectal cancer harbors tremendous heterogeneity, with temporal and spatial differences in genetic...
The high heterogeneity has become apparent in metastatic colorectal cancer (CRC) and the solitary le...
Colorectal cancer harbors tremendous heterogeneity, with temporal and spatial differences in genetic...
BACKGROUND: Colorectal cancer (CRC) is with approximately 1 million cases the third most common canc...
BACKGROUND: Approximately 4% of colorectal cancer (CRC) patients have at least two simultaneous canc...
The recognition that colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behavio...
Background: Colorectal cancer is a major global public health problem that has predominantly been co...
Background: Colorectal cancer is a major global public health problem that has predominantly been co...
Advanced colorectal cancer harbors extensive intratumor heterogeneity shaped by neutral evolution; h...
Background: Colorectal cancer is a major global public health problem that has predominantly been co...
Colorectal cancer (CRC) is one of the most common cancers and one of the leading causes of cancer de...
Background & aims: there are few validated biomarkers that can be used to predict outcomes for patie...